lipid x has been researched along with Sepsis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Danner, RL; Doerfler, ME; Parrillo, JE; Stuetz, P; Van Dervort, AL | 1 |
| Craig, WA; Golenbock, DT; Leggett, JE; Proctor, RA; Raetz, CR; Rasmussen, P | 1 |
2 other study(ies) available for lipid x and Sepsis
| Article | Year |
|---|---|
Antiendotoxin activity of lipid A analogues: requirements of the chemical structure.
Topics: Bacterial Infections; Chemical Phenomena; Chemistry; Endotoxins; Glycolipids; Humans; In Vitro Techniques; Lipid A; Myristic Acids; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Sepsis; Superoxides; Trypan Blue | 1990 |
Lipid X protects mice against fatal Escherichia coli infection.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Escherichia coli Infections; Glycolipids; Mice; Penicillins; Sepsis; Ticarcillin | 1988 |